Cargando…
Diagnosing Lung Cancer: The Complexities of Obtaining a Tissue Diagnosis in the Era of Minimally Invasive and Personalised Medicine
The role of the respiratory physician in diagnosing lung cancer has increased in complexity over the last 20 years. Adenocarcinoma is now the prevailing histopathological sub-type of non-small cell lung cancer (NSCLC) resulting in more peripheral cancers. Conventional bronchoscopy is often not suffi...
Autores principales: | McLean, Anna E. B., Barnes, David J., Troy, Lauren K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068581/ https://www.ncbi.nlm.nih.gov/pubmed/29966246 http://dx.doi.org/10.3390/jcm7070163 |
Ejemplares similares
-
Pharmacogenomics in the era of personalised medicine
por: White, Cassandra, et al.
Publicado: (2022) -
Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
por: Hunter, Francis W, et al.
Publicado: (2016) -
Reconciling art and science in the era of personalised medicine: the legacy of Georges Canguilhem
por: Contino, Gianmarco
Publicado: (2023) -
New era of personalised epilepsy management
por: Chen, Zhibin, et al.
Publicado: (2020) -
Machine learning in hypertension: from diagnosis to personalised medicine
por: eBioMedicine
Publicado: (2023)